An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of uncertain source.
Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, risking penalties, legal action or prison.
Service Response and Content Elimination
According to TikTok, the service has taken down violative material and prohibited related keywords and query recommendations. The organization stated it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.
Digital Trading Activities
Research also discovered groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, filled with photos of weight loss, glowing reviews and detailed guides for mixing or administering at home.
Within minutes of joining one group, a vendor posted contact information, where the majority of transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.
Product Information and Costs
Inside these groups, messages display black plastic parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram said it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is valid, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly serious medical dangers”.
